<DOC>
	<DOCNO>NCT00208091</DOCNO>
	<brief_summary>This study use computerize method musical instrument digital interface ( MIDI ) quantification performance treatment botulinum toxin type B ( Myobloc ® , Solstice Neurosciences ) . Myobloc purify diluted form botulinum toxin use medically relax unwanted muscle spasm movement . The aim study determine feasibility quantify change performance follow treatment .</brief_summary>
	<brief_title>Quantifying Musical Performance After Treatment With Myobloc Musician 's Dystonia</brief_title>
	<detailed_description>Dystonia represent group clinical disorder characterize various combination sustain involuntary muscle contraction , abnormal posture movement , tremor pain . Dystonia occur rest likely appear voluntary activity . Focal dystonia affect one body area include blepharospasm , oromandibular dystonia , spasmodic dysphonia , torticollis , limb dystonia . Focal dystonia typically present task-specific muscle spasm `` occupational cramp '' learn repetitive motor task ( write play musical instrument ) trigger muscle spasm interfere performance action remain normal . Writer 's cramp common form idiopathic limb dystonia [ 1-3 ] involuntary muscle activity abnormal posture affect arm hand , virtually part body may affect , even lips play woodwind brass instrument [ 4 ] . Patients may develop two focal dystonias rarely focal dystonia progress generalize form . As originally define Oppenheim [ 5 ] , dystonia refers slow , sustain , writhe , contort movement dystonia musculorum deformans . Dystonic movement , however , often rapid [ 6 ] cause misdiagnosis . Electromyography ( EMG ) may helpful corroborate dystonia , essential diagnostic purpose . Nerve conduction study , short long loop reflex analysis motor unit normal [ 7 , 8 ] . Ballistic movement , normally tri-phasic pattern alternate agonist-antagonist burst , may show disrupted pattern co-contraction agonist antagonist muscle excessively long EMG burst dystonia [ 3 ] . Dystonic spasms intrigue may suppress ( trigger ) sensory input postural change , tactile stimulus , alternative movement even think process [ 9 ] . Studies reveal involuntary muscle spasm may due , least part , abnormal sensory processing spindle afferent information [ 10-12 ] . This may help explain nature sensory `` trick '' well effect treatment use botulinum toxin usually outlast weakness creates . Though pathophysiology musician ' dystonia yet determine fully , motor learning associate play musical instrument probably result functional structural change brain [ 13 ] . This plastic reorganization , include rapid unmasking exist neural circuitry establishment new connection , probably fundamental accomplishment skillful playing , also may result focal , task-specific dystonia . When musician get dystonia , play ability become severely compromised , point may able perform professionally , possibly even teach . While botulinum toxin injection highly successful allow musician perform , objective method evaluate improvement . Subtle dystonic abnormality motor control , therefore , particularly involve arm , difficult ascertain high level certainty . There truly objective measure arm dystonia , problematic arm involvement present mildly go unnoticed examiner [ 14 ] . Furthermore , patient may complain mild finger thumb cramping , arm twisting shoulder elevation could signify presence dystonia . Clinical rating scale , even validate , detect subtle motor dysfunction small change treatment [ 15 ] certainly determine improvement musical performance . Metabolic image study use positron emission tomography ( PET ) study emerge helpful ancillary test , invasive expensive . Furthermore , PET study implicate primary dystonia may associate relative hypermetabolism putamen [ 16 ] , conflict report [ 17 ] . Another major difficulty study musician 's dystonias lack objective , quantifiable method ass degree dystonia severity measure treatment effect . Subjective objective clinical rating scale vary degree sophistication . Some subjective method use include subjective quantification usually use percentage improvement , also different various subjective rating scale use survey . This study test novel method devise quantify change musical performance base musical instrument digital interface ( MIDI ) data able directly rate score change musical output . MIDI data include information note play , time onset , note duration , note loudness . Note duration loudness use study . It quantitative , objective computerize evaluation compare patient ' fine motor skill treatment Myobloc ® . It one first quantitative analysis musical ability kind could significantly impact way musician determine efficacy botulinum toxin treatment . REFERENCES 1 . Nutt JG , Muenter MD , Melton LJ , Aronson A , Kurland LT . Epidemiology dystonia Rochester , Minnesota . Adv Neurol 1988 ; 50 : 361-5 . 2 . Sheehy MP , Marsden CD . Writers ' cramp - focal dystonia . Brain 1982 ; 105 : 461-480 . 3 . Cohen LG , Hallett M. Hand cramp : clinical feature electromyographic pattern focal dystonia . Neurology 1988 ; 38 : 1005-1012 . 4 . Frucht S , Fahn S , Ford B. French horn embouchure dystonia . Mov Disord 1999 ; 14 : 171-3 . 5 . Oppenheim H. Uber eine eigenartige Krampfkrankheit de kindlichen und jungendichen Alters ( dysbasia lordotica progressiva , dystonia musculorum deformans ) . Neurologie Centralblatt 1911 ; 30 : 1090-1107 . 6 . Fahn S. Concept classification dystonia . In Fahn , S , Marsden , CD , Caln , DB , ed . Advances Neurology : Dystonia 2 . New York : Raven Press , 1988 : 1-8 . 7 . Rothwell JC , Obeso JA , Day BL , Marsden CD . Pathophysiology dystonias . In Desmedt , JE , ed . Advances Neurology : Motor Control Mechanisms Health Disease . New York : Raven Press , 1983 : 851-863 . 8 . Marsden CD , Rothwell JC . The physiology idiopathic dystonia . Can J Neurol Sci 1987 ; 14 : 521-527 . 9 . Greene PE , Bressman S. Exteroceptive interoceptive stimulus dystonia . Mov Disord 1998 ; 13 : 549-51 . 10 . Tempel L , Perlmutter J. Abnormal vibration-induced cerebral blood flow response idiopathic dystonia . Brain 1990 ; 113 : 691-707 . 11 . Kaji R , Rothwell JC , Katayama M , Tomoko I , Kubori T , Kohara N , Mezaki T , Shibasaki H , Kimura J . Tonic vibration reflex muscle afferent block writer 's cramp . Ann Neurol 1995 ; 38 : 155-162 . 12 . Koelman JHTM , Willemse RB , Bour LJ , Hilgevoord AAJ , Speelman JD , Ongerboer de Visser BW . Soleus H-reflex test dystonia . Mov Disord 1995 ; 10 : 44-50 . 13 . Pascual-Leone A . The brain play music change . Ann N Y Acad Sci 2001 ; 930 : 315-29 . 14 . Bressman SB , de Leon D , Kramer PL , Ozelius LJ , Brin MF , Greene PE , Fahn S , Breakefield XO , Risch NJ . Dystonia Ashkenazi Jews : Clinical characterization founder mutation . Ann Neurol 1994 ; 36 : 771-777 . 15 . Burke RE , Fahn S , Marsden CD , Bressman SB , Moskowitz C , Friedman J. Validity reliability rating scale primary torsion dystonias . Neurology 1985 ; 35 : 73-77 . 16 . Eidelberg D , Moeller JR , Ishikawa T , Dhawan V , Spetsieris P , Przedborski S , Fahn S. The metabolic topography idiopathic torsion dystonia . Brain 1995 ; 118 : 1473-1484 . 17 . Karbe H , Holthoff VA , Rudolf J , Herholz K , Heiss WD . Positron emission tomography demonstrate frontal cortex basal ganglia hypometabolism dystonia . Neurology 1992 ; 42 : 1540-1544 . 18 . Pullman SL . Limb dystonia : Use botulinum toxin . In Jankovic , J , Hallett , M , ed . Therapeutic Use Botulinum Toxin . New York : Marcel Dekker , 1994 : 307-321 . 19 . Medical Research Council Aids Examination Peripheral Nervous System ; Crown : London , 1976 . 20 . Pullman SL , Greene P , Fahn S , Pedersen SF . Approach treatment limb disorder botulinum toxin A . Experience 187 patient . Arch Neurol 1996 ; 53 : 617-24 . 21 . Cohen LG , Hallett M , Geller BD , Hochberg F. Treatment focal dystonias hand botulinum toxin injection . J Neurol Neurosurg Psychiatry 1989 ; 52 : 355-363 . 22 . Trosch RM , Pullman SL . Botulinum toxin A injection treatment hand tremor . Mov Disord 1994 ; 9 : 601-9 .</detailed_description>
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<mesh_term>rimabotulinumtoxinB</mesh_term>
	<criteria>Focal , taskspecific dystonia clinically determine result high level musical skill intensive performance history Neurological disorder dystonia Patients clinically depress , demented otherwise unable perform appropriately sit 1 hour test Patients undergone pallidotomy , thalamotomy deep brain stimulator implantation Patients recently take medication extrapyramidal tremorogenic side effect</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Myloboc</keyword>
	<keyword>Botulinum Toxin Type B</keyword>
	<keyword>Focal Dystonia</keyword>
	<keyword>Musicians</keyword>
	<keyword>Muscle Relaxants</keyword>
	<keyword>Motor Impairments</keyword>
	<keyword>Motor Performance</keyword>
	<keyword>Tremor</keyword>
	<keyword>Abnormal Postures</keyword>
</DOC>